These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36091625)

  • 1. Development of a deprescribing manual for frail older people for use in the COFRAIL study and in primary care.
    Mann NK; Schmiedl S; Mortsiefer A; Bencheva V; Löscher S; Ritzke M; Drewelow E; Feldmeier G; Santos S; Wilm S; Thürmann PA;
    Ther Adv Drug Saf; 2022; 13():20420986221122684. PubMed ID: 36091625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
    Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
    JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home.
    Russell P; Hewage U; McDonald C; Thompson C; Woodman R; Mangoni AA
    Ther Adv Drug Saf; 2021; 12():20420986211052344. PubMed ID: 34707803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study.
    Antonelli MT; Cox JS; Saphirak C; Gurwitz JH; Singh S; Mazor KM
    Ther Adv Drug Saf; 2022; 13():20420986221118143. PubMed ID: 36052398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding older patients' willingness to have medications deprescribed in primary care: a protocol for a cross-sectional survey study in nine European countries.
    Lüthold RV; Jungo KT; Weir KR; Geier AK; Scholtes B; Kurpas D; Wild DMG; Petrazzuoli F; Thulesius H; Lingner H; Assenova R; Poortvliet RKE; Lazic V; Rozsnyai Z; Streit S
    BMC Geriatr; 2022 Nov; 22(1):920. PubMed ID: 36451180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis.
    Shrestha S; Poudel A; Cardona M; Steadman KJ; Nissen LM
    Ther Adv Drug Saf; 2021; 12():20420986211052343. PubMed ID: 34707802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists.
    Lukacena KM; Keck JW; Freeman PR; Harrington NG; Huffmyer MJ; Moga DC
    Ther Adv Drug Saf; 2022; 13():20420986221116465. PubMed ID: 36003624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe.
    Shrestha S; Giri R; Sapkota HP; Danai SS; Saleem A; Devkota S; Shrestha S; Adhikari B; Poudel A
    Ther Adv Drug Saf; 2021; 12():20420986211019309. PubMed ID: 34211689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
    Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
    Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Impacts and Characteristics of Deprescribing Interventions in Older Adults: Protocol for a Systematic Review and Meta-analysis.
    Tremblay Z; Mumbere D; Laurin D; Sirois C; Furrer D; Poisblaud L; Carmichael PH; Farrell B; Tourigny A; Giguere A; Vedel I; Morais J; Kröger E
    JMIR Res Protoc; 2021 Dec; 10(12):e25200. PubMed ID: 34889771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.
    Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S
    BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults.
    Kouladjian O'Donnell L; Sawan M; Reeve E; Gnjidic D; Chen TF; Kelly PJ; Bell JS; Hilmer SN
    BMC Geriatr; 2020 Feb; 20(1):51. PubMed ID: 32050899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries.
    Jungo KT; Mantelli S; Rozsnyai Z; Missiou A; Kitanovska BG; Weltermann B; Mallen C; Collins C; Bonfim D; Kurpas D; Petrazzuoli F; Dumitra G; Thulesius H; Lingner H; Johansen KL; Wallis K; Hoffmann K; Peremans L; Pilv L; Šter MP; Bleckwenn M; Sattler M; van der Ploeg M; Torzsa P; Kánská PB; Vinker S; Assenova R; Bravo RG; Viegas RPA; Tsopra R; Pestic SK; Gintere S; Koskela TH; Lazic V; Tkachenko V; Reeve E; Luymes C; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2021 Jan; 21(1):19. PubMed ID: 33413142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.
    Bolmsjö BB; Palagyi A; Keay L; Potter J; Lindley RI
    BMC Fam Pract; 2016 Nov; 17(1):152. PubMed ID: 27814691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.